Biomarker-enhanced VTE risk stratification in ambulatory patients with cancer

Shaw Joseph R.; Kumar Vaibhav; Mallick Ranjeeta; Carrier Marc; Ilich Anton; Key Nigel S.; Wells Philip

首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Biomarker-enhanced VTE risk stratification in ambulatory patients with cancer

【24h】

Biomarker-enhanced VTE risk stratification in ambulatory patients with cancer

机译：生物标志物增强癌症患者的VTE风险分层

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Introduction:Risk assessment models are used to stratify cancer patients according to their underlying risk of VTE. The CATS score has been shown to enhance VTE risk stratification as compared to the modified Khorana score by incorporating d-dimer and soluble p-selectin measurements. Our aim was to evaluate the performance of the CATS score with respect to VTE risk stratification.

机译：简介：风险评估模型用于根据癌症患者VTE的潜在风险对其进行分层。通过结合d-二聚体和可溶性p-选择素的测量，与改良的霍拉纳评分相比，CATS评分显示出增强VTE风险分层。我们的目的是评估CATS评分在VTE风险分层方面的表现。

著录项

来源
《Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis 》 |2020年第1期| 共7页
作者
Shaw Joseph R.; Kumar Vaibhav; Mallick Ranjeeta; Carrier Marc; Ilich Anton; Key Nigel S.; Wells Philip;
展开▼
作者单位

Univ Ottawa Dept Med Ottawa ON Canada;

Univ N Carolina Dept Med Chapel Hill NC USA;

Univ Ottawa Dept Med Ottawa ON Canada;

Univ Ottawa Dept Med Ottawa ON Canada;

Univ N Carolina Dept Med Chapel Hill NC USA;

Univ N Carolina Dept Med Chapel Hill NC USA;

Univ Ottawa Dept Med Ottawa ON Canada;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学 ;
关键词
Biomarkers; Humans; Risk factors; Venous thromboembolism; Factor Xa inhibitors; Neoplasms/complications;

机译：生物标志物;人类;危险因素;静脉血栓栓塞;因子XA抑制剂;肿瘤/并发症;

相似文献

外文文献
中文文献
专利

1. Risk-stratification model to select conversion surgery for advanced gastric cancer patients [J] . Runcong Nie, Shuqiang Yuan, Yuanfang Li, 中国癌症研究（英文版） . 2019 ,第001期
2. Oncological results, functional outcomes and health-related quality-of-life in men who received a radical prostatectomy or external beam radiation therapy for localized prostate cancer: a study on long-term patient outcome with risk stratification [J] . Itsuhiro Takizawa, Noboru Hara, Tsutomu Nishiyama, 亚洲男性学杂志（英文版） . 2009 ,第003期
3. The emerging role of prostate-specific membrane antigen(PSMA)PET-CT in patients with high-risk prostate cancer:moving the bar in high-risk prostate cancer [J] . Jeanny B Aragon-Ching 亚洲男性学杂志（英文版） . 2021 ,第001期
4. Ambulatory blood-pressure monitoring, antihypertensive therapy and the risk of fall injuries in elderly hypertensive patients [J] . Michael Jonas, Rasisa Kazarski, Gil Chemin 老年心脏病学杂志（英文版） . 2018 ,第004期
5. Enhanced VTE Risk Stratification in Ambulatory Patients with Cancer [J] . Shaw J., Mallick R., Carrier M., Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis . 2019 ,第期

机译：增强了癌症患者的VTE风险分层
6. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States [J] . Khorana Alok A., Dalal Mehul, Lin Jay, Cancer: A Journal of the American Cancer Society . 2013 ,第3期

机译：在美国接受化学疗法的门诊高危癌症患者中静脉血栓栓塞（VTE）的发生率和预测因素
7. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States [J] . Khorana Alok A., Dalal Mehul, Lin Jay, Cancer: A Journal of the American Cancer Society . 2013 ,第3期

机译：静脉血栓栓塞（VTE）在美国进行化疗的静脉血栓栓塞（VTE）的发病率和预测
8. Application for VTE stratification and risk assessment [C] . João Pavão, Rute Bastardo, Luis Torres Pereira, Iberian Conference on Information Systems and Technologies . 2017

机译：申请VTE分层和风险评估
9. A review of the management of patients at risk for or diagnosed with venous thromboembolism (VTE) at an academic medical center; and the cost-effectiveness of diagnostic strategies for VTE [D] . Lee, Jung-Ah 2008

机译：在学术医学中心对有风险或被诊断患有静脉血栓栓塞（VTE）的患者的管理进行审查；和VTE诊断策略的成本效益
10. The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification [O] . C. Michael Gibson, Alex C. Spyropoulos, Alexander T. Cohen, 2017

机译：IMPROVEDD VTE风险评分：将D-Dimer纳入IMPROVE评分以改善静脉血栓栓塞风险分层
11. P1246Age-, body size-, and sex-specific reference values for tricuspid valve apparatus parameters by real-time three-dimensional transthoracic echocardiographyP1247Surgical therapy in infective endocarditis: predisposing and prognostic factorsP1248Evalutation of MV annulus geometry modifications before and after mitraclip implantation with 3D transesophageal echocardiographyP1249Prognostic echocardiographic parameters for successful transcatheter edge-to-edge mitral valve repairP1250Influence of body surface area in diagnosis and outcome patient-prosthesis mismatch after TAVI. Is it necessary to adjust for ideal body weight?P1251Outcome of paradoxical low-flow low-gradient severe AS following TAVI: paradoxical VS parallel to outcome of high gradient ASP1252Prognostic role of cardiac calcifications in subjects without overt significant heart disease and previous cardiovascular events: is there an additive value over cardiovascular risk factors scores?P1253Aging degeneration of mitral valve without leaflet prolapse or tethering as a cause of severe mitral regurgitationP1254Cardiovascular risk assessment should be performed in patients with incidental aortic sclerosisP1255Cardiac valve calcification score: simple 2D echocardiographic tool for cardiovascular risk stratification in patients with chronic renal failureP1256Diastolic mitral regurgitation following transcatheter aortic valve replacement: prevalence, predictors and impact on outcomesP1257Timing of myocardial shortening determines left ventricular regional remodelling in hearts with conduction delaysP1258Myocardial stiffness assessment using shear wave imaging in healthy children and hypertrophic cardiomyopathyP1259Assessment of right ventricular response to exercise using vector velocity imaging in hypertrophic cardiomyopathyP1260Diagnostic value of cardiac biomarkers (high sensitive troponin T and N-terminal pro-brain natriuretic peptide) in patients with infiltrative cardiomyopathiesP1261Right ventricular global longitudinal strain differentiates between adolescent patients with definite, borderline and possible ARVC and controlsP1262 echogrqphic predictif factors of atrial arrhythmias in patients with arrhythmogenic right ventricular dysplasiaP1263Importance of combined left atrial size and estimated pulmonary pressure for clinical outcome in patients presenting with heart failure with preserved ejection fractionP1264Chronotropic response in mitochondrial (ANT1) cardiomyopathyP1265 The effect of cardiovascular risk factors and cancer type in anthracycline's cardiotoxicityP1266Revisiting the echocardiographic features of acute myocarditisP1267Altered circulation in fetuses of diabetic mothers: a fetal computational model analysisP1268Increased epicardial adipose tissue is related to stress-induced cardiomyopathyP1269Contrast enhanced ultrasound of kidney perfusion in patients with renal artery stenosis: diagnostic and prognostic applications. [O] . F. Ancona, R. Ilhao Moreira, V. Lavanco, 2016

机译：P1246age-，身体大小和性别特异性参考Tricuspid阀装置参数通过实时三维经线性超声心动图124772777777747774747478EVALIGUTALMEXP1249预期植入前后MV环形植入前后MV环空性修饰。超声心动图参数用于成功的经截管边缘到边缘二尖瓣修复P1250中的体表面积诊断和结果患者假体在Tavi后的不匹配。是否有必要调整理想的体重？P1251矛盾的低流量低梯度严重，如Tavi：矛盾的VS平行于高梯度ASP1252的结果，在没有明显显着的心脏病和以前心血管事件的情况下心脏钙化的促傲作用患有心血管危险因素的添加剂值分数？没有传单脱垂的二尖瓣退化或作为严重二尖瓣血管血管血管病风险评估的患者进行脱垂或系绳，应当在偶然主动脉源肺源P1255Cariac阀钙化评分患者中进行：用于心血管风险分层的简单2D超声心动图工具在慢性肾功能衰竭的患者中，经沟管主动脉瓣膜置换术后：流行率，预测因子和对Otcomasp1257的影响，心肌缩短决定了导通延迟的心中的剩余心室区域重新耦合258MYCIARIAL僵硬评估使用剪切波成像在健康儿童和肥厚性心肌脑病中的舒缓性心脏响应，在渗透心肌肌瘤患者中使用载体速度成像的培养速度成像（高敏感的肌钙蛋白T和N-末端脑Natrietic肽）渗透心肌病，患者心室全局纵向菌株在患有心律失常右心室发育不良患者的心理心律失常患者中的青少年患者与Controlsp1262 echogrqphic预测因子的分歧，患者心血性右心室发育不良患者患者患者患者患者患者患者患者患者患者线粒体（ANT1）心肌病患者的喷射FRACTIONP1264系列响应1265心血管危险因素和癌症类型在蒽丙烯的心肌毒性皮1126660中的影响访问患有糖尿病母亲胎儿胎儿急性心肌炎的超声心动图，患者患者：胎儿计算模型分析P1268增加外膜脂肪组织与肾动脉狭窄患者肾脏灌注的应激诱导的心肌病，增强超声波：诊断和预后应用。
12. Developing a PTEN-ERG Signature to Improve Molecular Risk Stratification in Prostate Cancer. [R] . Lotan, T. 2017

机译：开发pTEN-ERG标志以改善前列腺癌的分子风险分层。

Biomarker-enhanced VTE risk stratification in ambulatory patients with cancer

摘要

著录项

相似文献

相关主题

期刊订阅